Wikipedia

Clostridium perfringens

(Redirected from Tissue gas)

Clostridium perfringens (formerly known as C. welchii, or Bacillus welchii) is a Gram-positive, bacillus (rod-shaped), anaerobic, spore-forming pathogenic bacterium of the genus Clostridium.[1][2] C. perfringens is ever-present in nature and can be found as a normal component of decaying vegetation, marine sediment, the intestinal tract of humans and other vertebrates, insects, and soil. It has the shortest reported generation time of any organism at 6.3 minutes in thioglycolate medium.[3]

Clostridium perfringens
Photomicrograph of Gram-positive Clostridium perfringens bacilli
Scientific classification Edit this classification
Domain: Bacteria
Phylum: Bacillota
Class: Clostridia
Order: Eubacteriales
Family: Clostridiaceae
Genus: Clostridium
Species:
C. perfringens
Binomial name
Clostridium perfringens
Veillon & Zuber 1898
Hauduroy et al. 1937

Clostridium perfringens is one of the most common causes of food poisoning in the United States, alongside norovirus, Salmonella, Campylobacter, and Staphylococcus aureus.[4] However, it can sometimes be ingested and cause no harm.[5]

Infections due to C. perfringens show evidence of tissue necrosis, bacteremia, emphysematous cholecystitis, and gas gangrene, also known as clostridial myonecrosis. The specific name, perfringens, is derived from the Latin per (meaning "through") and frango ("burst"), referring to the disruption of tissue that occurs during gas gangrene.[6] The toxin involved in gas gangrene is α-toxin, which inserts into the plasma membrane of cells, producing gaps in the membrane that disrupt normal cellular function. C. perfringens can participate in polymicrobial anaerobic infections. It is commonly encountered in infections as a component of the normal flora. In this case, its role in disease is minor.

C. perfringens toxins are a result of horizontal gene transfer of a neighboring cell's plasmids.[7] Shifts in genomic make-up are common for this species of bacterium and contribute to novel pathogensis.[8] Major toxins are expressed differently in certain populations of C. perfringens; these populations are organized into strains based on their expressed toxins.[9] This especially impacts the food industry, as controlling this microbe is important for preventing foodborne illness.[8] Novel findings in C. perfringens hyper-motility, which was provisionally thought as non-motile, have been discovered as well.[10] Findings in metabolic processes reveal more information concerning C. perfringens pathogenic nature.[11]

Genome

edit

Clostridium perfringens has a stable G+C content around 27 to 28 percent and average genome size of 3.5 Mb.[12] Genomes of 56 C. perfringens strains have since been made available on the NCBI genomes database for the scientific research community. Genomic research has revealed surprisingly high diversity in C. perfringens pangenome, with only 12.6 percent core genes, identified as the most divergent Gram-positive bacteria reported.[12] Nevertheless, 16S rRNA regions in between C. perfringens strains are found to be highly conserved (sequence identity >99.1%).[12]

The Clostridium perfringens enterotoxin (CPE)–producing strain has been identified to be a small portion of the overall C. perfringens population (~1-5%) through genomic testing.[13] Advances in genetic information surrounding strain A CPE C. perfringens has allowed techniques such as microbial source tracking (MST) to identify food contamination sources.[13] The CPE gene has been found within chromosomal DNA as well as plasmid DNA. Plasmid DNA has been shown to play and integral role in cell pathogenesis and encodes for major toxins, including CPE.[7]

C. perfringens has been shown to carry plasmid-containing genes for antibiotic resistance. The pCW3 plasmid is the primary conjugation plasmid responsible for creating antibiotic resistance in C. perfringens. Furthermore, the pCW3 plasmid also encodes for multiple toxins found in pathogenic strains of C. perfringens.[14] Antibiotic resistance genes observed thus far include tetracycline resistance, efflux protein, and aminoglycoside resistance.[15]

Within industrial contexts, such as food production, sequencing genomes for pathogenic strains of C. perfringens has become an expanding field of research. Poultry production is impacted directly from this trend as antibiotic-resistant strains of C. perfringens are becoming more common.[8] By performing a meta-genome analysis, researches are capable to identify novel strains of pathogenic bacterium, such as C. perfringens B20.[8]

Motility

edit

Clostridium perfringens is provisionally identified as non-motile. They lack flagella; however, recent research suggests gliding as a form of motility.[16][17]

Hyper-motile variations

edit
 
This illustration depicts a three-dimensional (3D), computer-generated image of a cluster of barrel-shaped, Clostridium perfringens bacteria. The artistic recreation was based upon scanning electron microscopic (SEM) imagery.

In agar plate cultures bacteria with hypermotile variations like SM101 frequently appear around the borders of the colonies. They create long thin filaments that enable them to move quickly, much like bacteria with flagella, according to video imaging of their gliding motion. The causes of the hypermotile phenotype and its immediate descendants were found using genome sequencing. The hypermotile offspring of strains SM101 and SM102, SM124 and SM127, respectively, had 10 and 6 nucleotide polymorphisms (SNPs) in comparison to their parent strains. The hypermotile strains have the common trait of gene mutations related to cell division.[16]

Regulation of gliding motility: The CpAL/VirSR system

edit

Some strains of C. perfringens cause various diseases like gas gangrene and myonecrosis. Toxins produced that are required for myonecrosis is regulated by the C. perfringens Agr-like (CpAl) system through the VirSR two-component system. The CpAL/VirSR system is a quorum sensing system encoded by other pathogenic clostridia. Myonecrosis starts at the infection site and involves bacteria migrating deeper via gliding motility. Researchers investigated if the CpAL/VirSR system regulates gliding motility. The study demonstrated that the CpAL/VirSR regulates C. perfringensgliding motility. Additionally, the study suggests that gliding bacteria in myonecrosis have increased transcription of toxin genes.[17]

Transformation

edit
Main article: Transformation (genetics)

There are two methods of genetic manipulation via experimentation that have been shown to cause genetic transformation in C. perfringens.

Protoplast transformation

edit

The first report of transformation in C. perfringens involved polyethylene glycol-mediated transformation of protoplasts. The transformation procedure involved the addition of the plasmid DNA to the protoplasts in the presence of high concentrations of polyethylene glycol. During the first protoplast transformation experiment, L-phase variants of C. perfringens were generated by penicillin treatment in the presence 0.4m sucrose. After the transformation procedure was completed, all of the transformed cells were still in the form of L-phase variants. Reversion to vegetative cells was not obtained, but it was observed that autoplasts (protoplasts derived from autolysis) were able to be regenerated to produce rods with cell walls and could be transformed with C. perfringens plasmid DNA.[18]

Electroporation

edit

Electroporation involves the application of a high-voltage electric field to vegetative bacteria cells for a very short period. This technique resulted in major advances in genetic transformation of C. perfringens, due to the bacteria often displaying itself as a vegetative cell or as dormant spores in food.[19] The electric pulse creates pores in the bacterial cell membrane and allows the passive influx of DNA molecules.[20]

Transmission and pathogenesis

edit

C. perfringens is most commonly known for foodborne illness, but can translocate from a gastrointestinal source into the bloodstream which causes bacteremia. C. perfringens bacteremia can lead to toxin-mediated intravascular hemolysis and septic shock.[21] This is rare as it makes up less than 1% of bloodstream isolates, but is highly fatal with a reported mortality rate of 27% to 58%.[22]

Clostridium perfringens is the most common bacterial agent for gas gangrene. Some symptoms include blisters, tachycardia, swelling, and jaundice.[23]

A strain of C. perfringens might be implicated in multiple sclerosis (MS) nascent (Pattern III) lesions.[24] Tests in mice found that a two strains of intestinal C. perfringens that produced epsilon toxins (ETX) caused MS-like damage in the brain, and earlier work had identified this strain of C. perfringens in a human with MS.[25][26] MS patients were found to be 10 times more immune-reactive to the epsilon toxin than healthy people.[27]

Perfringolysin O (pfoA)-positive C. perfringens strains were also associated with the rapid onset of necrotizing enterocolitis in preterm infants.[28]

Metabolic processes

edit

C. perfringens is an aerotolerant anaerobe bacterium that lives in a variety of environments including soil and human intestinal tract.[11] C. perfringens is incapable of synthesizing multiple amino acids due to the lack of genes required for biosynthesis.[11] Instead, the bacterium produces enzymes and toxins to break down host cells and import nutrients from the degrading cell.[11]

C. perfringens has a complete set of enzymes for glycolysis and glycogen metabolism. In the fermentation pathway, pyruvate is converted into acetyl-CoA by pyruvate-ferredoxin oxidoreductase, producing CO2 gas and reduced ferredoxin.[29] Electrons from the reduced ferredoxin are transferred to protons by hydrogenase, resulting in the formation of hydrogen molecules (H2) that are released from the cell along with CO2. Pyruvate is also converted to lactate by lactate dehydrogenase, whereas acetyl-CoA is converted into ethanol, acetate, and butyrate through various enzymatic reactions, completing the anaerobic glycolysis that serves as a potential main energy source for C. perfringens. C. perfringens utilizes a variety of sugars such as fructose, galactose, glycogen, lactose, maltose, mannose, raffinose, starch, and sucrose, and various genes for glycolytic enzymes. The amino acids of these various enzymes and sugar molecules are converted to propionate through propionyl-CoA, which results in energy production.[29]

Virulence

edit

Membrane-damaging enzymes, pore-forming toxins, intracellular toxins, and hydrolytic enzymes are the functional categories into which C. perfringens' virulence factors may be divided. These virulence factor-encoding genes can be found on chromosomes and large plasmids.[30]

Carbohydrate-active enzymes

edit

The human gastrointestinal tract is lined with a protective layer called the intestinal mucosa. The function of intestinal mucosa is to secrete mucus and act as a defense mechanism against pathogens, toxins, and harmful substances. Within the mucus is mucin, an O-glycan glycoprotein that recognizes and forms a barrier around invaders and prevents them from attaching to endothelial cells and infecting them.[31][32] C. perfringens can secrete different carbohydrate-active enzymes used to degrade mucins and other O-glycans within the intestinal mucosa. These enzymes include: Sialidase, Hexosaminidase, Galactosidase, Fucosidase, and Complementary enzymes belonging to various glycoside hydrolase families.[32]

Sialidase

edit

Sialidases, also called neuraminidases, function to breakdown mucin by hydrolyzing the terminal sialic acid residues located within the protein through the process of desialylation. C. perfringens has three sialidases belonging to glycoside hydrolase family 33 (GH33): NanH, NanI, and NanJ.[32][33]

C. perfringens secretes and releases NanI and NanJ, but NanH does not have a secretion signal peptide and is believed to operate in the cytoplasm. NanH has only one catalytic domain, while NanI and NanJ contain additional carbohydrate-binding modules (CBMs). NanI contains an N-terminal CBM40, whereas NanJ has an N-terminal CBM40 as well as an N-terminal CBM32.[32]

Studies on the three-dimensional structure of NanI show that there is an active site with a pocket-like shape, allowing for the removal of sialic acid residues from sialomucins in the intestinal mucosa.[32]

Hexosaminidase

edit

The mucus layer consists of intestinal mucin glycans, glycolipids, and glycoproteins that contain hexosamines, such as N-acetylglucosamine (GlcNAc) and N-acetylgalactosamine (GalNAc). C. perfringens encodes for eight hexosaminidases that break down hexosamines in the mucus. These hexosaminidases belong to four glycoside hydrolase families: GH36, GH84, GH89, and GH123.[32]

C. perfringens has two hexosaminidases in GH36: AagA (CpGH36A), which removes GalNAc from O-glycans, and the predicted CpGH36B, whose exact function is still unknown but is expected to have a similar structure.[32]

NagH, NagI, NagJ, and NagK belong to GH84. They are known to cleave terminal GlcNAc residues using a specific mechanism.[32]

AgnC (CpGH89), belonging to GH89, releases N-acetyl-D-glucosamine from class III mucins and can act on gastric mucin.[32]

CpNga123, belonging to GH123, cleaves β-D-GalNAc found in glycosphingolipids. Unlike the other enzymes, it does not have a signal for secretion and is thought to work on glycans taken up into the bacterial cell.[32]

Galactosidase

edit

C. perfringens has four galactosidases that belong to the glycoside hydrolase family 2 (GH2): CpGH2A, CpGH2B, CpGH2C, and CpGH2D. Research suggests that these enzymes are effective at breaking down core mucin glycan structures. However, as research is limited on galactosidases in C. perfringens, the exact functioning of these enzymes are unknown.[32]

Fucosidase

edit

Fucose monosaccharides are located on the terminal ends of core O-linked glycans. Clostridium perfringens has three α-L-fucosidases belonging to two different families: Afc1 (GH29), Afc2 (GH29), and Afc3 (GH95). These fucosyl residues typically cap the ends of glycans, providing protection against enzymatic digestion.[32]

Major toxins

edit

There are five major toxins produced by Clostridium perfringens. Alpha, beta, epsilon and enterotoxin are toxins that increase a cells permeability which causes an ion imbalance while iota toxins destroy the cell's actin cytoskeleton.[34] On the basis of which major, "typing" toxins are produced, C. perfringens can be classified into seven "toxinotypes", A, B, C, D, E, F and G:[35]

Toxinotypes of C. perfringens[35]: fig.1 [36]
Toxin
Type
 Alpha Beta Epsilon Iota Enterotoxin NetB Notes
A + - -
B + + - -
C + + - +/- -
D + - + - +/- -
E + - + +/- -
F + - + -
G + - +

Alpha toxin

edit

Alpha toxin (CPA) is a zinc-containing phospholipase C, composed of two structural domains, which destroy a cell's membrane. Alpha toxins are produced by all five types of C. perfringens. This toxin is linked to gas gangrene of humans and animals. Most cases of gas gangrene has been related to a deep wound being contaminated by soil that harbors C. perfringens.[34][37]

Beta toxin

edit

Beta toxins (CPB) are a protein that causes hemorrhagic necrotizing enteritis and enterotoxaemia in both animals (type B) and humans (type C) which leads to the infected individual's feces becoming bloody and their intestines necrotizing.[34] Proteolytic enzymes, such as trypsin, can break down CPB, making them ineffective. Therefore, the presence of trypsin inhibitors in colostrum makes CPB especially deadly for mammal offspring.[38]

Epsilon toxin

edit

Epsilon toxin (ETX) is a protein produced by type B and type D strains of C. perfringens. This toxin is currently ranked the third most potent bacterial toxin known.[39] ETX causes enterotoxaemia in mainly goats and sheep, but cattle are sometime susceptible to it as well. An experiment using mice found that ETX had an LD50 of 50-110 ng/kg.[40] The excessive production of ETX increases the permeability of the intestines. This causes severe edema in organs such as the brain and kidneys.[41]

The very low LD50 of ETX has led to concern that it may be used as a bioweapon. It appeared on the select agent lists of the US CDC and USDA, until it was removed in 2012. There are no human vaccines for this toxin, but effective vaccines for animals exist.[42]

Iota toxin

edit

Iota toxin (ITX) is a protein produced by type E strains of C. perfringens. Iota toxins are made up of two, unlinked proteins that form a multimeric complex on cells. Iota toxins prevent the formation of filamentous actin. This causes the destruction of the cells cytoskeleton which in turn leads to the death of the cell as it can no longer maintain homeostasis.[43]

Enterotoxin

edit

This toxin (CPE) causes food poisoning. It alters intracellular claudin tight junctions in gut epithelial cells. This pore-forming toxin also can bind to human ileal and colonic epithelium in vitro and necrotize it. Through the caspase-3 pathway, this toxin can cause apoptosis of affected cells. This toxin is linked to type F strains, but has also been found to be produced by certain types of C, D, and E strains.[44]

Other toxins

edit

TpeL is a toxin found in type B, C, and G[45] strains. It is in the same protein family as C. difficile toxin A.[46] It does not appear important in the pathogenesis of types B and C infections, but may contribute to virulence in type G strains. It glycosylates Rho and Ras GTPases, disrupting host cell signaling.[45]

Infection

edit

Infections due to C. perfringens show evidence of tissue necrosis, bacteremia, emphysematous cholecystitis, and gas gangrene, also known as clostridial myonecrosis. The toxin involved in gas gangrene is α-toxin, which inserts into the plasma membrane of cells, producing gaps in the membrane that disrupt normal cellular function. C. perfringens can participate in polymicrobial anaerobic infections.[citation needed]

Clostridium perfringens food poisoning can also lead to another disease known as enteritis necroticans or clostridial necrotizing enteritis, (also known as pigbel); this is caused by C. perfringens type C. This infection is often fatal. Large numbers of C. perfringens grow in the intestines, and secrete exotoxin. This exotoxin causes necrosis of the intestines, varying levels of hemorrhaging, and perforation of the intestine. Inflammation usually occurs in sections of the jejunum, midsection of the small intestine. This disease eventually leads to septic shock and death. This particular disease is rare in the United States; typically, it occurs in populations with a higher risk. Risk factors for enteritis necroticans include protein-deficient diet, unhygienic food preparation, sporadic feasts of meat (after long periods of a protein-deficient diet), diets containing large amounts of trypsin inhibitors (sweet potatoes), and areas prone to infection of the parasite Ascaris (produces a trypsin inhibitor). This disease is contracted in populations living in New Guinea, parts of Africa, Central America, South America, and Asia.[47]

Tissue gas occurs when C. perfringens infects corpses. It causes extremely accelerated decomposition, and can only be stopped by embalming the corpse. Tissue gas most commonly occurs to those who have died from gangrene, large decubitus ulcers, necrotizing fasciitis or to those who had soil, feces, or water contaminated with C. perfrigens forced into an open wound.[48] These bacteria are resistant to the presence of formaldehyde in normal concentrations.[citation needed]

Food poisoning

edit

C. perfringens forms spores that are distributed through air, soil, and water. The most common cause of illness comes from the ingestion of poorly cooked meats that are contaminated by these spores.[49] After this meat is left out at 20 °C to 60 °C, the spores germinate and C. perfringens then grows rapidly. The bacteria produce a toxin that causes diarrhea.[50]

Food poisoning in humans is caused by type A strains able to produce C. perfringens enterotoxin.[51] This enterotoxin is a polypeptide of 35.5 kDa that accumulates in the beginning of the sporulation, and is excreted to the media when it lysates at the end of the sporulation. It is coded by the cpe gene, which is present in less than 5% of the type A strains, and it can be located in the chromosome or in an external plasmid[52]

In the United Kingdom and United States, C. perfringens bacteria are the third-most common cause of foodborne illness, with poorly prepared meat and poultry, or food properly prepared, but left to stand too long, the main culprits in harboring the bacterium.[53] The C. perfringens enterotoxin that mediates the disease is heat-labile (inactivated at 74 °C (165 °F)). It can be detected in contaminated food (if not heated properly), and feces.[54] Incubation time is between 6 and 25 (commonly 10–12) hours after ingestion of contaminated food.[55]

Since C. perfringens forms spores that can withstand cooking temperatures, if cooked food is left standing for long enough, germination can ensue and infective bacterial colonies develop. Symptoms typically include abdominal cramping, diarrhea, and fever.[47] The whole course usually resolves within 24 hours, but can last up to 2 weeks in older or infirm hosts.[56] Despite its potential dangers, C. perfringens is used as the leavening agent in salt-rising bread. The baking process is thought to reduce the bacterial contamination, precluding negative effects.[5]

Many cases of C. perfringens food poisoning likely remain subclinical, as antibodies to the toxin are common among the population. This has led to the conclusion that most of the population has experienced food poisoning due to C. perfringens.[citation needed]

Epidemiology

edit

Clostridium perfringens is a leading cause of food poisoning in the United States and Canada.[57] Contaminated meats in stews, soups, and gravies are usually responsible for outbreaks and cause about 1 million cases of foodborne illnesses in the United States every year.[58] Deaths due to the disease are rare and mostly occur in elderly and people who are predisposed to the disease.[59] From 1998 to 2010, 289 confirmed outbreaks of C. perfringens illness were reported with 15,208 illnesses, 82 hospitalizations, and eight deaths.[60]

Food poisoning incidents

edit

On May 7, 2010, 42 residents and 12 staff members at a Louisiana (USA) state psychiatric hospital were affected and experienced vomiting, abdominal cramps, and diarrhea. Three patients died within 24 hours. The outbreak was linked to chicken which was cooked a day before it was served and was not cooled down according to hospital guidelines. The outbreak affected 31% of the residents of the hospital and 69% of the staff who ate the chicken. How many of the affected residents ate the chicken is unknown.[61]

In May 2011, a man died after allegedly eating food contaminated with the bacteria on a transatlantic American Airlines flight. The man's wife and daughter were suing American and LSG Sky Chefs, the German company that prepared the inflight food.[62]

In December 2012, a 46-year-old woman died two days after eating a Christmas Day meal at a pub in Hornchurch, Essex, England. She was among about 30 people to fall ill after eating the meal. Samples taken from the victims contained C. perfringens. The hotel manager and the cook were jailed for offences arising from the incident.[63]

In December 2014, 87-year-old Bessie Scott died three days after eating a church potluck supper in Nackawic, New Brunswick, Canada. Over 30 other people reported signs of gastrointestinal illness, diarrhea, and abdominal pain. The province's acting chief medical officer says, Clostridium perfringens is the bacteria [sic] that most likely caused the woman's death.[64]

In October 2016, 66-year-old Alex Zdravich died four days after eating an enchilada, burrito, and taco at Agave Azul in West Lafayette, Indiana, United States. Three others who dined the same day reported signs of foodborne illness, which were consistent with the symptoms and rapid onset of C. perfringens infection. They later tested positive for the presence of the bacteria, but the leftover food brought home by Zdravich tested negative.[65][66]

In November 2016, food contaminated with C. perfringens caused three individuals to die, and another 22 to be sickened, after a Thanksgiving luncheon hosted by a church in Antioch, California, United States.[67]

In January 2017, a mother and her son sued a restaurant in Rochester, New York, United States, as they and 260 other people were sickened after eating foods contaminated with C. perfringens. "Officials from the Monroe County Department of Public Health closed down the Golden Ponds after more than a fourth of its Thanksgiving Day guests became ill. An inspection revealed a walk-in refrigerator with food spills and mold, a damaged gasket preventing the door from closing, and mildew growing inside."[68]

In July 2018, 647 people reported symptoms after eating at a Chipotle Mexican Grill restaurant in Powell, Ohio, United States. Stool samples tested by the CDC tested positive for C. perfringens.[69]

In November 2018, approximately 300 people in Concord, North Carolina, United States, were sickened by food at a church barbecue that tested positive for C. perfringens.[70]

In 2021, dozens of hospital workers in Alaska were sick and it was traced back to a Cubano Sandwich. Health officials wrote that almost all symptoms resolved within 24 hours. No one who ate the food reportedly needed hospitalization. It is rare for Alaska to see an outbreak with this magnitude when it's not associated with some sort of national food borne illness.[71]

Clinical manifestations and diagnosis

edit

Clostridium perfringens infections can lead to a variety of clinical manifestations, ranging from mild gastrointestinal symptoms to life-threatening conditions. The most common presentation is food poisoning, characterized by acute abdominal pain, diarrhea, and, in some cases, vomiting, typically occurring 6 to 24 hours after ingestion of contaminated food. [72] In more severe cases, particularly with the C. perfringens type A strain, individuals may develop necrotizing enteritis, which can cause severe abdominal pain, fever, and systemic symptoms due to intestinal necrosis. [73] Additionally, C. perfringens can be implicated in gas gangrene, a rapidly progressing soft tissue infection that presents with severe pain, swelling, and the presence of gas in tissues.[74] These varied clinical manifestations highlight the importance of prompt diagnosis and treatment to mitigate severe outcomes associated with C. perfringens infections.

In the diagnosis of Clostridium perfringens, Nagler's reaction serves as a useful test. This method involves culturing the organism on an egg yolk agar plate, where one side is treated with anti-alpha-toxin while the other side remains untreated. When a streak of the suspect organism is applied across both sides, turbidity forms around the side lacking the anti-alpha-toxin. This turbidity indicates uninhibited lecithinase activity, a hallmark of C. perfringens due to its production of alpha-toxin. This reaction effectively differentiates C. perfringens from other bacterial species.[75]

Typically, the symptoms of C. perfringens poisoning are used to diagnose it. However, diagnosis can be made using a stool culture test, in which the feces are tested for toxins produced by the bacteria.[76]

Prevention

edit

Most foods, notably beef and chicken, can be prevented from growing C. perfringens spores by cooking them to the necessary internal temperatures. The best way to check internal temperatures is by using kitchen thermometers.[56] The temperature that C. perfringens can multiply within can range anywhere from 59 °F (15 °C) to 122 °F (50 °C).[77] After two hours of preparation, leftover food should be chilled to a temperature of less than 40 °F (4 °C). Large pots of soup or stew that contain meats should be split into smaller portions and refrigerated with a lid on. Before serving, leftovers must be warmed to at least 165 °F (74 °C). As a general rule, food should be avoided if it tastes, smells, or appears differently than it should. Food that has been out for a long period might also be unsafe to eat, even if it appears healthy.[56]

Treatment

edit

The most important aspect of treatment is prompt and extensive surgical debridement of the involved area and excision of all devitalized tissue, in which the organisms are prone to grow. Administration of antimicrobial drugs, particularly penicillin, is begun at the same time. Clostridium perfringens is more often susceptible to vancomycin compared to other pathogenic Clostridia and 20% of the strains are resistant to clindamycin.[78] Metronidazole resistance is also relatively common, with a resistance rate of 10%.[79] Hyperbaric oxygen may be of help in the medical management of clostridial tissue infections.[80] Most people who suffer from food poisoning caused by C. perfringens tend to fight off the illness without the need of any antibiotics. Extra fluids should be drank consistently until diarrhea dissipates.[58]

References

edit
  1. ^ Ryan, Kenneth J.; Ray, C. George (2004). Sherris Medical Microbiology : an Introduction to Infectious Diseases (4th ed.). New York: McGraw-Hill. p. 310. ISBN 978-0-8385-8529-0.
  2. ^ Kiu, R; Hall, L. J. (2018). "An update on the human and animal enteric pathogen Clostridium perfringens". Emerging Microbes & Infections. 7 (141): 141. doi:10.1038/s41426-018-0144-8. PMC 6079034. PMID 30082713.
  3. ^ "BioNumber Details Page". BioNumbers.
  4. ^ "Foodborne Illnesses and Germs". Centers for Disease Control and Prevention (CDC). 2018-02-16. Retrieved 18 February 2018.
  5. ^ a b Juckett, G; Bardwell, G; McClane, B; Brown, S (2008). "Microbiology of salt rising bread". The West Virginia Medical Journal. 104 (4): 26–7. PMID 18646681.
  6. ^ Lexicon Orthopaedic Etymology. CRC Press. 1999. p. 128. ISBN 9789057025976.
  7. ^ a b Gulliver, Emily L.; Adams, Vicki; Marcelino, Vanessa Rossetto; Gould, Jodee; Rutten, Emily L.; Powell, David R.; Young, Remy B.; D’Adamo, Gemma L.; Hemphill, Jamia; Solari, Sean M.; Revitt-Mills, Sarah A.; Munn, Samantha; Jirapanjawat, Thanavit; Greening, Chris; Boer, Jennifer C. (2023-04-20). "Extensive genome analysis identifies novel plasmid families in Clostridium perfringens". Microbial Genomics. 9 (4). doi:10.1099/mgen.0.000995. ISSN 2057-5858. PMC 10210947. PMID 37079454. S2CID 258238878.
  8. ^ a b c d Elnar, Arxel G.; Kim, Geun-Bae (2021-11-30). "Complete genome sequence of Clostridium perfringens B20, a bacteriocin-producing pathogen". Journal of Animal Science and Technology. 63 (6): 1468–1472. doi:10.5187/jast.2021.e113. ISSN 2672-0191. PMC 8672250. PMID 34957460.
  9. ^ Revitt-Mills, Sarah A; Rood, Julian I; Adams, Vicki (2015). "Clostridium perfringens extracellular toxins and enzymes: 20 and counting". Microbiology Australia. 36 (3): 114. doi:10.1071/MA15039. ISSN 1324-4272.
  10. ^ Wambui, Joseph; Cernela, Nicole; Stevens, Marc J. A.; Stephan, Roger (2021-09-13). "Whole Genome Sequence-Based Identification of Clostridium estertheticum Complex Strains Supports the Need for Taxonomic Reclassification Within the Species Clostridium estertheticum". Frontiers in Microbiology. 12. doi:10.3389/fmicb.2021.727022. ISSN 1664-302X. PMC 8473909. PMID 34589074.
  11. ^ a b c d Ohtani, Kaori; Shimizu, Tohru (2016-07-05). "Regulation of Toxin Production in Clostridium perfringens". Toxins. 8 (7): 207. doi:10.3390/toxins8070207. ISSN 2072-6651. PMC 4963840. PMID 27399773.
  12. ^ a b c Kiu, Raymond; Caim, Shabhonam; Alexander, Sarah; Pachori, Purnima; Hall, Lindsay J. (2017). "Probing Genomic Aspects of the Multi-Host Pathogen Clostridium perfringens Reveals Significant Pangenome Diversity, and a Diverse Array of Virulence Factors". Frontiers in Microbiology. 8: 2485. doi:10.3389/fmicb.2017.02485. PMC 5733095. PMID 29312194.
  13. ^ a b Miyamoto, Kazuaki; Li, Jihong; McClane, Bruce A. (2012). "Enterotoxigenic Clostridium perfringens: Detection and Identification". Microbes and Environments. 27 (4): 343–349. doi:10.1264/jsme2.ME12002. ISSN 1342-6311. PMC 4103540. PMID 22504431. S2CID 7743606.
  14. ^ Adams, Vicki; Han, Xiaoyan; Lyras, Dena; Rood, Julian I. (September 2018). "Antibiotic resistance plasmids and mobile genetic elements of Clostridium perfringens". Plasmid. 99: 32–39. doi:10.1016/j.plasmid.2018.07.002. PMID 30055188. S2CID 51866356.
  15. ^ Kiu, Raymond; Caim, Shabhonam; Alexander, Sarah; Pachori, Purnima; Hall, Lindsay J. (2017-12-12). "Probing Genomic Aspects of the Multi-Host Pathogen Clostridium perfringens Reveals Significant Pangenome Diversity, and a Diverse Array of Virulence Factors". Frontiers in Microbiology. 8: 2485. doi:10.3389/fmicb.2017.02485. ISSN 1664-302X. PMC 5733095. PMID 29312194.
  16. ^ a b Liu, Hualan; McCord, Kristin D.; Howarth, Jonathon; Popham, David L.; Jensen, Roderick V.; Melville, Stephen B. (July 2014). "Hypermotility in Clostridium perfringens Strain SM101 Is Due to Spontaneous Mutations in Genes Linked to Cell Division". Journal of Bacteriology. 196 (13): 2405–2412. doi:10.1128/JB.01614-14. ISSN 0021-9193. PMC 4054169. PMID 24748614.
  17. ^ a b Valeriani, Renzo G.; Beard, LaMonta L.; Moller, Abraham; Ohtani, Kaori; Vidal, Jorge E. (2020-12-01). "Gas gangrene-associated gliding motility is regulated by the Clostridium perfringens CpAL/VirSR system". Anaerobe. 66: 102287. doi:10.1016/j.anaerobe.2020.102287. ISSN 1075-9964. PMID 33130105.
  18. ^ Rood, J I; Cole, S T (December 1991). "Molecular genetics and pathogenesis of Clostridium perfringens". Microbiological Reviews. 55 (4): 621–648. doi:10.1128/mr.55.4.621-648.1991. ISSN 0146-0749. PMC 372840. PMID 1779929.
  19. ^ Golden, Neal J.; Crouch, Edmund A.; Latimer, Heejeong; Kadry, Abdel-Razak; Kause, Janell (July 2009). "Risk Assessment for Clostridium perfringens in Ready-to-Eat and Partially Cooked Meat and Poultry Products". Journal of Food Protection. 72 (7): 1376–1384. doi:10.4315/0362-028x-72.7.1376. ISSN 0362-028X. PMID 19681258.
  20. ^ Rood, J I; Cole, S T (1991). "Molecular genetics and pathogenesis of Clostridium perfringens". Microbiological Reviews. 55 (4): 621–648. doi:10.1128/MMBR.55.4.621-648.1991. ISSN 0146-0749. PMC 372840. PMID 1779929.
  21. ^ "Cytarabine". Reactions Weekly. 1959 (1): 223. 2023-06-03. doi:10.1007/s40278-023-40395-7. ISSN 1179-2051. S2CID 259027022.
  22. ^ Millard, Michael A.; McManus, Kathleen A.; Wispelwey, Brian (2016). "Severe Sepsis due to Clostridium perfringens Bacteremia of Urinary Origin: A Case Report and Systematic Review". Case Reports in Infectious Diseases. 2016: 1–5. doi:10.1155/2016/2981729. ISSN 2090-6625. PMC 4779822. PMID 26998370.
  23. ^ "Gas gangrene: MedlinePlus Medical Encyclopedia".
  24. ^ Rumah, Kareem Rashid; Linden, Jennifer; Fischetti, Vincent A.; Vartanian, Timothy; Esteban, Francisco J. (16 October 2013). "Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease". PLOS ONE. 8 (10): e76359. Bibcode:2013PLoSO...876359R. doi:10.1371/journal.pone.0076359. PMC 3797790. PMID 24146858.
  25. ^ "Multiple sclerosis 'linked to food bug'". BBC. 29 January 2014. Retrieved 29 January 2014.
  26. ^ Reder, Anthony T. (2023-05-01). "Clostridium epsilon toxin is excessive in multiple sclerosis and provokes multifocal lesions in mouse models". Journal of Clinical Investigation. 133 (9). doi:10.1172/JCI169643. ISSN 1558-8238. PMC 10145922. PMID 37115699. S2CID 258375399.
  27. ^ Woerner, Amanda (29 January 2014). "Bacterial toxin may trigger multiple sclerosis, research finds". Fox News.
  28. ^ Kiu, Raymond; Shaw, Alexander G.; Sim, Kathleen; Acuna-Gonzalez, Antia; Price, Christopher A.; Bedwell, Harley; Dreger, Sally A.; Fowler, Wesley J.; Cornwell, Emma; Pickard, Derek; Belteki, Gusztav; Malsom, Jennifer; Phillips, Sarah; Young, Gregory R.; Schofield, Zoe (June 2023). "Particular genomic and virulence traits associated with preterm infant-derived toxigenic Clostridium perfringens strains". Nature Microbiology. 8 (6): 1160–1175. doi:10.1038/s41564-023-01385-z. ISSN 2058-5276. PMC 10234813. PMID 37231089.
  29. ^ a b Shimizu, Tohru; Ohtani, Kaori; Hirakawa, Hideki; Ohshima, Kenshiro; Yamashita, Atsushi; Shiba, Tadayoshi; Ogasawara, Naotake; Hattori, Masahira; Kuhara, Satoru; Hayashi, Hideo (2002-01-22). "Complete genome sequence of Clostridium perfringens , an anaerobic flesh-eater". Proceedings of the National Academy of Sciences. 99 (2): 996–1001. Bibcode:2002PNAS...99..996S. doi:10.1073/pnas.022493799. ISSN 0027-8424. PMC 117419. PMID 11792842.
  30. ^ Revitt-Mills, Sarah A; Rood, Julian I; Adams, Vicki (2015). "Clostridium perfringens extracellular toxins and enzymes: 20 and counting". Microbiology Australia. 36 (3): 114. doi:10.1071/MA15039. ISSN 1324-4272.
  31. ^ Ba, Xuli; Jin, Youshun; Ning, Xuan; Gao, Yidan; Li, Wei; Li, Yunhui; Wang, Yihan; Zhou, Jizhang (2024-08-07). "Clostridium perfringens in the Intestine: Innocent Bystander or Serious Threat?". Microorganisms. 12 (8): 1610. doi:10.3390/microorganisms12081610. ISSN 2076-2607. PMC 11356505. PMID 39203452.
  32. ^ a b c d e f g h i j k l Low, Kristin E; Smith, Steven P; Abbott, D Wade; Boraston, Alisdair B (2020-05-30). "The glycoconjugate-degrading enzymes of Clostridium perfringens: Tailored catalysts for breaching the intestinal mucus barrier". Glycobiology. 31 (6): 681–690. doi:10.1093/glycob/cwaa050. ISSN 1460-2423. PMID 32472136.
  33. ^ Medley, Brendon J.; Low, Kristin E.; Irungu, Jackline D. W.; Kipchumba, Linus; Daneshgar, Parandis; Liu, Lin; Garber, Jolene M.; Klassen, Leeann; Inglis, G. Douglas; Boons, Geert-Jan; Zandberg, Wesley F.; Abbott, D. Wade; Boraston, Alisdair B. (2024-10-01). "A "terminal" case of glycan catabolism: Structural and enzymatic characterization of the sialidases of Clostridium perfringens". Journal of Biological Chemistry. 300 (10): 107750. doi:10.1016/j.jbc.2024.107750. ISSN 0021-9258.
  34. ^ a b c Stiles, Bradley G.; Barth, Gillian; Barth, Holger; Popoff, Michel R. (2013-11-12). "Clostridium perfringens Epsilon Toxin: A Malevolent Molecule for Animals and Man?". Toxins. 5 (11): 2138–2160. doi:10.3390/toxins5112138. ISSN 2072-6651. PMC 3847718. PMID 24284826.
  35. ^ a b Johnston MD, Whiteside TE, Allen ME, Kurtz DM (February 2022). "Toxigenic Profile of Clostridium perfringens Strains Isolated from Natural Ingredient Laboratory Animal Diets". Comparative Medicine. 72 (1): 50–58. doi:10.30802/AALAS-CM-22-000013. PMC 8915413. PMID 35148812.
  36. ^ Rood, Julian I.; Adams, Vicki; Lacey, Jake; Lyras, Dena; McClane, Bruce A.; Melville, Stephen B.; Moore, Robert J.; Popoff, Michel R.; Sarker, Mahfuzur R.; Songer, J. Glenn; Uzal, Francisco A.; Van Immerseel, Filip (2018-10-01). "Expansion of the Clostridium perfringens toxin-based typing scheme". Anaerobe. 53: 5–10. doi:10.1016/j.anaerobe.2018.04.011. ISSN 1075-9964. PMC 6195859. PMID 29866424.
  37. ^ Li, Ming; Li, Ning (2021-06-16). "Clostridium perfringens bloodstream infection secondary to acute pancreatitis: A case report". World Journal of Clinical Cases. 9 (17): 4357–4364. doi:10.12998/wjcc.v9.i17.4357. ISSN 2307-8960. PMC 8173429. PMID 34141801.
  38. ^ Garcia, J.P.; Beingesser, J.; Fisher, D.J.; Sayeed, S.; McClane, B.A.; Posthaus, H.; Uzal, F.A. (4 January 2012). "The effect of Clostridium perfringens type C strain CN3685 and its isogenic beta toxin null mutant in goats". Veterinary Microbiology. 157 (3–4): 412–419. doi:10.1016/j.vetmic.2012.01.005. PMC 3348370. PMID 22296994.
  39. ^ Alves, Guilherme Guerra; Machado de Ávila, Ricardo Andrez; Chávez-Olórtegui, Carlos Delfin; Lobato, Francisco Carlos Faria (2014-12-01). "Clostridium perfringens epsilon toxin: The third most potent bacterial toxin known". Anaerobe. 30: 102–107. doi:10.1016/j.anaerobe.2014.08.016. ISSN 1075-9964. PMID 25234332.
  40. ^ Xin, Wenwen; Wang, Jinglin (2019-09-01). "Clostridium perfringens epsilon toxin: Toxic effects and mechanisms of action". Biosafety and Health. 1 (2): 71–75. doi:10.1016/j.bsheal.2019.09.004. ISSN 2590-0536. S2CID 208690896.
  41. ^ Geng, Zhijun; Kang, Lin; Huang, Jing; Gao, Shan; Wang, Jing; Yuan, Yuan; Li, Yanwei; Wang, Jinglin; Xin, Wenwen (2021-07-30). "Epsilon toxin from Clostridium perfringens induces toxic effects on skin tissues and HaCaT and human epidermal keratinocytes". Toxicon. 198: 102–110. Bibcode:2021Txcn..198..102G. doi:10.1016/j.toxicon.2021.05.002. ISSN 0041-0101. PMID 33965432. S2CID 234343237.
  42. ^ Stiles, Bradley G.; Barth, Gillian; Popoff, Michel R. P (2018). "Clostridium Perfringens Epsilon Toxin". Medical Aspects of Biological Warfare (2 ed.). Health Readiness Center of Excellence (US Army). ISBN 9780160941597.
  43. ^ Sakurai, Jun; Nagahama, Masahiro; Oda, Masataka; Tsuge, Hideaki; Kobayashi, Keiko (2009-12-23). "Clostridium perfringens Iota-Toxin: Structure and Function". Toxins. 1 (2): 208–228. doi:10.3390/toxins1020208. ISSN 2072-6651. PMC 3202787. PMID 22069542.
  44. ^ Kiu, Raymond; Hall, Lindsay J. (2018-12-01). "An update on the human and animal enteric pathogen Clostridium perfringens". Emerging Microbes & Infections. 7 (1): 141. doi:10.1038/s41426-018-0144-8. ISSN 2222-1751. PMC 6079034. PMID 30082713.
  45. ^ a b Orrell, KE; Melnyk, RA (18 August 2021). "Large Clostridial Toxins: Mechanisms and Roles in Disease". Microbiology and Molecular Biology Reviews. 85 (3): e0006421. doi:10.1128/MMBR.00064-21. PMC 8483668. PMID 34076506.
  46. ^ Chen, J; McClane, BA (June 2015). "Characterization of Clostridium perfringens TpeL toxin gene carriage, production, cytotoxic contributions, and trypsin sensitivity". Infection and Immunity. 83 (6): 2369–81. doi:10.1128/IAI.03136-14. PMC 4432761. PMID 25824828.
  47. ^ a b Lentino, Joseph R. (2016-01-01). "Clostridial Necrotizing Enteritis". Merck Manuel. Merck Sharp & Dohme Corp. Retrieved 2016-09-27.
  48. ^ "Clostridium perfringens" (PDF). ldh.la.gov/. Louisiana Office of Public Health. Retrieved 14 June 2024.
  49. ^ "Prevent Illness From C. perfringens", CDC
  50. ^ "Clostridium perfringens Food Poisoning - Infectious Diseases". Merck Manuals Professional Edition. Retrieved 2023-10-17.
  51. ^ Kiu, Raymond; Caim, Shabhonam; Painset, Anais; Pickard, Derek; Swift, Craig; Dougan, Gordon; Mather, Alison E.; Amar, Corinne; Hall, Lindsay J. (25 September 2019). "Phylogenomic analysis of gastroenteritis-associated Clostridium perfringens in England and Wales over a 7-year period indicates distribution of clonal toxigenic strains in multiple outbreaks and extensive involvement of enterotoxin-encoding (CPE) plasmids". Microbial Genomics. 5 (10). doi:10.1099/mgen.0.000297. PMC 6861862. PMID 31553300.
  52. ^ Labbe, R.G.; Juneja, V.K. (2017), "Clostridium perfringens", Foodborne Diseases, Elsevier, pp. 235–242, doi:10.1016/b978-0-12-385007-2.00010-3
  53. ^ Warrell; et al. (2003). Oxford Textbook of Medicine (4th ed.). Oxford University Press. ISBN 978-0-19-262922-7.[page needed]
  54. ^ Murray; et al. (2009). Medical Microbiology (6th ed.). Mosby Elsevier. ISBN 978-0-323-05470-6.[page needed]
  55. ^ Fafangel, Mario; UČacar, Veribuca; Vudrag, Marko; Berce, Ingrid; Kraigher, Alenka (2015). "A Five Site Clostridium Perfringens Food-Borne Outbreak: A Retrospective Cohort Study". Slovenian Journal of Public Health. 54 (1): 51–57. doi:10.1515/sjph-2015-0007. PMC 4820149. PMID 27646622.
  56. ^ a b c "Clostridium perfringens". Center for Disease Control and Prevention. 2015-10-08. Retrieved 2016-09-27.
  57. ^ Johnson, E. A., Summanen, P., & Finegold, S. M. (2007). Clostridium. In P. R. Murray (Ed.), Manual of Clinical Microbiology (9th ed., pp. 889-910). Washington, D.C.: ASM Press
  58. ^ a b CDC (2023-03-24). "Prevent Illness From C. perfringens". Centers for Disease Control and Prevention. Retrieved 2023-10-01.
  59. ^ Songer, J. G. (2010). Clostridia as agents of zoonotic disease. Veterinary Microbiology, 140(3-4), 399-404
  60. ^ Grass, Julian E.; Gould, L. Hannah; Mahon, Barbara E. (1 February 2013). "Epidemiology of foodborne disease outbreaks caused by Clostridium perfringens, United States, 1998-2010". Foodborne Pathog. Dis. 10 (2): 131–136. doi:10.1089/fpd.2012.1316. PMC 4595929. PMID 23379281.
  61. ^ "Fatal Foodborne Clostridium perfringens Illness at a State Psychiatric Hospital — Louisiana, 2010". Centers for Disease Control and Prevention. Retrieved 16 November 2013.
  62. ^ Mohn, Tanya (1 December 2011). "Passenger dies in-flight, family says airline to blame". Overhead Bin. MSNBC. Retrieved 2012-02-13.
  63. ^ "Pub chef and manager jailed over Christmas dinner that left a diner dead". The Guardian. 23 January 2015. Retrieved 3 August 2015.
  64. ^ "Woman's death likely caused by bacteria from Christmas supper". CBC. 12 December 2014.
  65. ^ "Food poisoning death at Indiana restaurant kept secret for months". 13 WTHR Indianapolis. 2017-07-17. Archived from the original on 2017-07-20. Retrieved 2017-07-18.
  66. ^ (WTHR), Susan Batt. "Agave Azul Tippecanoe Co Food Poisoning Finding Summary". www.documentcloud.org. Retrieved 2017-07-18.
  67. ^ "Bacteria that killed 3 at Antioch Thanksgiving dinner pinpointed". SFGate. Retrieved 2016-12-20.
  68. ^ "Mother, son sue eatery for Thanksgiving dinner food poisoning - Food Safety News". 6 January 2017.
  69. ^ "CDC releases test findings after hundreds sickened at Powell Chipotle - Columbus Dispatch". 16 August 2018. Archived from the original on 16 August 2018. Retrieved 16 August 2018.
  70. ^ "Strain of food poisoning causes illness at North Carolina church barbecue". November 2018.
  71. ^ "Cubano Sandwiches with Clostridium Perfringens Found in Alaska Investigation". Food Safety News. August 12, 2021.
  72. ^ Friedman, C.R.; Neimark, H.; Slutsker, L. (2005). Foodborne Pathogens and Disease (2(3) ed.). pp. 207–213.
  73. ^ Stevens, D.L (1999). "Clostridial Myonecrosis" (PDF). Infectious Disease Clinics of North America. 13 (4): 1071–1085. doi:10.1007/s11908-010-0127-y. PMC 7135049. PMID 10579108. Retrieved 3 October 2024.
  74. ^ Miyamoto, K.; Ota, H.; Tanaka, M. (2019). "Gas gangrene due to Clostridium perfringens: a clinical review". The Journal of Infection and Chemotherapy. 25 (7): 511–516. doi:10.1016/j.jiac.2019.04.008. PMC 6641467. PMID 31135680.
  75. ^ Pati, Pradeep Kumar; Sahu, Sujata Kumari (2021). "Nagler's Reaction and its Application in Diagnosing Clostridium perfringens". Tropical Animal Health and Production. 53 (6): 124–132. doi:10.1016/j.parkreldis.2021.02.029. PMID 33745796.
  76. ^ "Bad Bug Book (Second Edition)" (PDF). U.S. Food and Drug Administration. 2014-10-07. Retrieved 2016-09-26.
  77. ^ Taormina, Peter J.; Dorsa, Warren J. (July 2004). "Growth Potential of Clostridium perfringens during Cooling of Cooked Meats". Journal of Food Protection. 67 (7): 1537–1547. doi:10.4315/0362-028X-67.7.1537. PMID 15270517.
  78. ^ Di Bella, Stefano; Antonello, Roberta Maria; Sanson, Gianfranco; Maraolo, Alberto Enrico; Giacobbe, Daniele Roberto; Sepulcri, Chiara; Ambretti, Simone; Aschbacher, Richard; Bartolini, Laura; Bernardo, Mariano; Bielli, Alessandra (June 2022). "Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey". Anaerobe. 75: 102583. doi:10.1016/j.anaerobe.2022.102583. hdl:11368/3020691. PMID 35568274. S2CID 248736289.
  79. ^ Geremia, Nicholas; Sanson, Gianfranco; Principe, Luigi; Antonello, Roberta Maria; Zerbato, Verena; Luzzati, Roberto; Maraolo, Alberto Enrico; Giacobbe, Daniele Roberto; Sepulcri, Chiara; Ambretti, Simone; Aschbacher, Richard; Bartolini, Laura; Bernardo, Mariano; Bielli, Alessandra; Busetti, Marina (2024). "A subanalysis of Clostridium perfringens bloodstream infections from a 5-year retrospective nationwide survey (ITANAEROBY)". Anaerobe. 90: 102901. doi:10.1016/j.anaerobe.2024.102901. PMID 39214165.
  80. ^ Jawetz Melnick & Adelbergs Medical Microbiology - 27E.
edit
Retrieved from "https://en.wikipedia.org/w/index.php?title=Clostridium_perfringens&oldid=1257128309#Tissue_gas"